Predictive Vulnerability Intelligence.

Product

  • Product
  • Pricing
  • Documentation

Company

  • About
  • Partnerships
  • Blog
  • Support

Legal

  • Terms
  • Privacy
  • Data Licensing

© 2026 FAUCET Technologies LLC. All rights reserved.

CVE-2024-48966

30
FAUCET Score

CVE-2024-48966 describes a critical vulnerability in the service tools used for ventilator testing and calibration, affecting an unspecified product. The vulnerability, rated 10.0 CVSS (Critical), stems from a lack of user authentication in these tools, allowing an unauthenticated attacker with access to the Service PC to obtain diagnostic information or manipulate ventilator settings and embedded software. There is no evidence of active exploitation, public exploit code, or inclusion in the CISA KEV catalog, though it has garnered significant community discussion with 10 mentions.

Impacted Technologies

VendorProductVersion(s)CPE
BaxterLife2000 Ventilation System
06.08.00.00 and priorCNA affecteddefault unaffected

CVSS Data

CVSS version used by this source: 3.1

10.0CRITICAL

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H

Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
NONE
User Interaction
NONE
Scope
CHANGED
Confidentiality Impact
HIGH
Integrity Impact
HIGH
Availability Impact
HIGH
Exploitability Score
3.9
Impact Score
6.0
CvssVersion
3.1

Exploit Intelligence

EPSS Score
0.68%
Probability of exploitation in next 30 days
EPSS Percentile
48.5%
Percentile rank of EPSS score among Peer Group
As of 2026-07-27
Model: v2026.06.15
This CVE's current EPSS score of 0.0068 is in the 30th percentile among its peer group of 36,862 CVEs.

Social Chatter

The average CVE in this peer group has 0.0 Twitter, 0.1 Reddit, 0.3 Bluesky, 0.3 Mastodon, and 2.4 GitHub mentions.

Media Mentions

No media coverage found for this CVE.

The average CVE in this peer group has 0.3 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.

Remediation

Remediation records are not available for this CVE.

References

cisa.gov / news-events/ics-medical-advisories/icsma-24-319-01